Atlas Trials

Safety and Efficacy of Oral Full-Spectrum Medicinal Cannabis Plant Extract in Children With Autism Spectrum Disorder.

Clinical trial NCT05516407 · UNKNOWN

Trial details

NCT number
NCT05516407
Sponsor
Fenix Innovation Group
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2021-04-01
Primary completion
2022-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.